ArticleClinical neuropsychiatry2026
How Evolutionary Psychiatry Can Help us Prevent Overmedicalisation.
Article in Clinical neuropsychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Overmedicalisation in the treatment of mental health problems occurs when normal emotional responses are inappropriately framed as disorders requiring primarily pharmacological intervention, or when social and environmental contributors to distress are overlooked in favour of a narrowly biological model. Critically, this risk is not confined to biological psychiatry: psychotherapeutic models are equally capable of framing ordinary human distress as requiring professional intervention. Evolutionary psychiatry (EP) broadens the scope of the standard biopsychosocial model to consider both individual level (ontogenetic) and species level (phylogenetic) development of emotional and psychological phenomena and associated behaviours. By understanding that many psychiatric symptoms, such as anxiety, low mood and hypervigilance, have phylogenetic roots as adaptive responses to ancestral environments, clinicians can better distinguish between normal variation and disabling or disorder-level pathology. EP also illuminates how mismatches between evolved psychological mechanisms and modern environments contribute to distress, suggesting non-pharmacological interventions may often be more effective. At the same time, the evolutionary criterion for distinguishing disorder from normal variation - while scientifically grounded - has limited utility in clinical practice, where cultural trends can push judgement towards either overmedicalisation or diagnostic nihilism. In this paper, we outline how an evolution-informed perspective can inform clinical reasoning, promote diagnostic discernment, and support a holistic, evobiopsychosocial approach to the prevention and treatment of psychiatric illness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.